ANIP: ANI Pharmaceuticals, Inc.
About
ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.
Current Value
$55.361 Year Return
Current Value
$55.361 Year Return
Key Details
Market Cap
$1.17B
P/E Ratio
-102.79
1Y Stock Return
7.49%
1Y Revenue Growth
23.60%
Dividend Yield
0.00%
Price to Book
2.9
Strategies that include ANIP
Stock's related to ANIP
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| KODK | 40.37% | $422.90M | +41.40% | 0.00% |
| USPH | 38.56% | $1.37B | +6.52% | 1.95% |
| IMXI | 38.05% | $651.21M | -1.55% | 0.00% |
| ARIS | 36.49% | $763.08M | +214.02% | 1.56% |
| ASH | 36.35% | $3.73B | -1.96% | 2.08% |
| SNBR | 36.27% | $263.31M | +5.09% | 0.00% |
| BBSI | 35.49% | $1.08B | +53.09% | 1.64% |
| ESTA | 35.36% | $968.33M | +54.98% | 0.00% |
| VERX | 35.20% | $7.99B | +89.70% | 0.00% |
| PGEN | 34.68% | $228.91M | -28.00% | 0.00% |
| PLYA | 34.43% | $1.16B | +23.51% | 0.00% |
| ZUMZ | 34.35% | $409.63M | +17.32% | 0.00% |
| NVRO | 34.28% | $158.88M | -73.60% | 0.00% |
| ODP | 34.25% | $777.35M | -46.62% | 0.00% |
| SBH | 34.25% | $1.33B | +35.54% | 0.00% |
| OKTA | 34.18% | $12.66B | +4.91% | 0.00% |
| CNDT | 34.01% | $569.21M | +20.27% | 0.00% |
| BIGC | 33.69% | $473.42M | -31.75% | 0.00% |
| ACEL | 33.21% | $940.36M | +12.85% | 0.00% |
| MRC | 33.17% | $1.13B | +25.09% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| AMBC | 0.01% | $584.50M | -17.09% | 0.00% |
| ARC | 0.02% | $146.66M | +18.95% | 5.90% |
| TXO | -0.03% | $737.26M | -1.80% | 13.22% |
| CANG | 0.06% | $253.50M | +212.50% | 0.00% |
| PAYX | -0.06% | $50.62B | +18.84% | 2.73% |
| SMWB | 0.07% | $1.01B | +134.25% | 0.00% |
| SLE | 0.07% | $8.82M | -63.18% | 0.00% |
| CYCN | -0.08% | $4.77M | -16.19% | 0.00% |
| MNOV | 0.09% | $93.19M | +2.15% | 0.00% |
| OKLO | 0.10% | $2.66B | +111.04% | 0.00% |
| MRK | -0.11% | $244.21B | -5.55% | 3.18% |
| CORZ | -0.11% | $4.60B | +3,201.26% | 0.00% |
| OCX | 0.12% | $42.93M | -36.09% | 0.00% |
| ACHV | -0.20% | $149.25M | -17.65% | 0.00% |
| MVO | -0.20% | $106.15M | -22.78% | 16.78% |
| APD | -0.22% | $72.92B | +18.69% | 2.14% |
| EDSA | -0.23% | $7.11M | -21.79% | 0.00% |
| AIXI | 0.26% | $43.94M | -72.60% | 0.00% |
| WHF | 0.28% | - | - | 14.53% |
| RDY | 0.28% | $11.97B | +5.10% | 3.31% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| GAN | -35.38% | $83.39M | +21.19% | 0.00% |
| STG | -19.42% | $35.67M | +7.92% | 0.00% |
| CBOE | -19.33% | $21.46B | +15.84% | 1.11% |
| DAVA | -17.57% | $1.16B | -59.28% | 0.00% |
| KRRO | -14.94% | $436.84M | +20.68% | 0.00% |
| FTNT | -11.32% | $69.59B | +72.67% | 0.00% |
| PULM | -11.03% | $19.83M | +202.98% | 0.00% |
| FATBB | -10.95% | $81.94M | -12.91% | 11.69% |
| AXON | -9.55% | $46.53B | +167.14% | 0.00% |
| HUSA | -9.52% | $16.69M | -11.56% | 0.00% |
| DT | -9.40% | $15.40B | -1.30% | 0.00% |
| REYN | -8.64% | $5.79B | +3.76% | 3.35% |
| CWAN | -8.48% | $6.77B | +47.68% | 0.00% |
| UUU | -8.32% | $4.97M | -41.89% | 0.00% |
| CPSH | -7.68% | $20.70M | -40.13% | 0.00% |
| QTTB | -6.74% | $354.34M | +188.64% | 0.00% |
| AMED | -6.67% | $2.95B | -3.95% | 0.00% |
| NARI | -6.61% | $2.98B | -11.66% | 0.00% |
| EXEL | -6.58% | $9.83B | +62.16% | 0.00% |
| HCI | -6.57% | $1.16B | +29.00% | 1.48% |
ETF's related to ANIP
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| RSPA | 45.50% | $273.87M | 0% |
| GSSC | 39.35% | $529.86M | 0.2% |
| PEJ | 39.24% | $257.98M | 0.57% |
| IWC | 39.01% | $933.99M | 0.6% |
| TMSL | 38.84% | $288.12M | 0.55% |
| IJT | 38.75% | $6.64B | 0.18% |
| SLYG | 38.48% | $3.69B | 0.15% |
| IWO | 38.31% | $12.56B | 0.24% |
| XSMO | 38.25% | $1.25B | 0.39% |
| VIOO | 38.19% | $3.12B | 0.1% |
| XSLV | 38.12% | $322.27M | 0.25% |
| IWM | 38.04% | $75.73B | 0.19% |
| FYX | 38.04% | $959.00M | 0.6% |
| SMMV | 38.02% | $321.07M | 0.2% |
| VTWO | 37.98% | $12.38B | 0.1% |
| PSC | 37.86% | $702.17M | 0.38% |
| FNY | 37.82% | $372.31M | 0.7% |
| XSHD | 37.78% | $54.49M | 0.3% |
| SPSM | 37.72% | $12.72B | 0.03% |
| ESML | 37.66% | $1.90B | 0.17% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| PREF | 0.43% | $999.92M | 0.55% |
| PDBC | 0.57% | $4.40B | 0.59% |
| XHLF | -1.22% | $874.27M | 0.03% |
| SOYB | 1.24% | $27.32M | 0.22% |
| DUSB | 1.27% | $797.63M | 0.15% |
| BOXX | 1.40% | $4.43B | 0.1949% |
| COMT | 1.45% | $829.06M | 0.48% |
| GSG | 1.57% | $914.42M | 0.75% |
| GBIL | 1.65% | $5.60B | 0.12% |
| USCI | 1.79% | $185.47M | 1.07% |
| AGZD | -1.81% | $142.76M | 0.23% |
| CORN | 1.91% | $61.12M | 0.2% |
| TOTL | 2.05% | $3.31B | 0.55% |
| ZROZ | 2.17% | $1.63B | 0.15% |
| GOVZ | 2.33% | $313.00M | 0.1% |
| DBC | 2.37% | $1.39B | 0.87% |
| PWZ | 2.39% | $697.36M | 0.28% |
| LGOV | 2.50% | $607.48M | 0.67% |
| SPTS | 2.54% | $5.71B | 0.03% |
| SGOV | 2.75% | $27.53B | 0.09% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -28.50% | $195.31M | 0.85% |
| BTAL | -25.27% | $388.04M | 1.43% |
| TAIL | -19.36% | $67.98M | 0.59% |
| ULST | -19.18% | $535.47M | 0.2% |
| DBE | -9.73% | $50.13M | 0.77% |
| HDRO | -8.35% | $164.26M | 0.3% |
| DBO | -8.23% | $217.57M | 0.77% |
| UNG | -8.00% | $908.80M | 1.06% |
| CTA | -7.50% | $350.27M | 0.78% |
| TBIL | -7.40% | $4.38B | 0.15% |
| USDU | -7.39% | $201.97M | 0.5% |
| CLOI | -7.22% | $715.40M | 0.4% |
| EQLS | -7.19% | $76.08M | 1% |
| WEAT | -7.17% | $120.27M | 0.28% |
| HIGH | -6.83% | $302.78M | 0.51% |
| UUP | -6.66% | $309.25M | 0.77% |
| KMLM | -5.39% | $353.87M | 0.9% |
| XBIL | -5.22% | $637.70M | 0.15% |
| CANE | -4.06% | $17.72M | 0.29% |
| DBA | -3.40% | $755.88M | 0.93% |
News
Yahoo
Here is how Adagene Inc. Sponsored ADR (ADAG) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year.
Finnhub
BAUDETTE - ANI Pharmaceuticals, Inc. today announced financial results and business highlights for the three months ended September 30, 2024.'I am very pleased to report our third quarter results...
Yahoo
ANI Pharmaceuticals ( NASDAQ:ANIP ) Third Quarter 2024 Results Key Financial Results Revenue: US$148.3m (up 13% from 3Q...
Yahoo
ANI Pharmaceuticals Inc (ANIP) reports a 13% revenue increase and raises full-year guidance, driven by Cortrophin Gel demand and strategic acquisitions.
SeekingAlpha
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q3 2024 Earnings Conference Call November 8, 2024 8:00 AM ETCompany ParticipantsLisa Wilson - IRNikhil Lalwani -...
Yahoo
The headline numbers for ANI (ANIP) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.